B
Biocrates Life Sciences
Biocrates Life Sciences AG, developer of targeted metabolic phenotyping solutions, supports the discovery and validation of biomarkers for complex diseases
About Biocrates Life Sciences
Biocrates is a company specializing in targeted metabolomics, providing ready-to-measure kits and services designed for quantitative, reproducible, and standardized mass spectrometry-based research. The company serves a diverse range of clients including academic researchers, clinical laboratories, and pharmaceutical companies. Operating in the biotechnology and healthcare market, Biocrates' business model revolves around the sale of metabolomics kits and the provision of related services. Revenue is generated through the direct sale of these kits and through service contracts for specialized metabolomics analysis. The company also engages in educational activities, offering webinars on topics such as nutrition, clinical metabolomics, and neurodegenerative diseases. By ensuring high-quality, reliable data, Biocrates supports scientific discoveries and advancements in personalized health.
Source: Dealroom company dataAt a glance
- Founded
- 2002
- Headquarters
- Innsbruck, Austria
- Sector
- Biotech & Life Sciences
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
MIG Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biocrates Life Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biocrates Life Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.